Reduction of serum cholesterol and lipids by ethyl chlorophenoxyisobutyrate
- 1 September 1963
- journal article
- research article
- Published by Elsevier in Journal of Atherosclerosis Research
- Vol. 3 (5-6), 454-466
- https://doi.org/10.1016/s0368-1319(63)80025-3
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- EFFECT OF ATROMID AND ETHYL CHLOROPHENOXYISOBUTYRATE ON ANTICOAGULANT REQUIREMENTSThe Lancet, 1963
- Cataracts in Patients Treated with TriparanolPublished by American Medical Association (AMA) ,1962
- EXPERIMENTAL EVALUATION OF AN ORALLY ACTIVE COMBINATION OF ANDROSTERONE WITH ETHYL CHLOROPHENOXYISOBUTYRATEThe Lancet, 1962
- REDUCTION OF SERUM-LIPID AND URIC-ACID LEVELS BY AN ORALLY ACTIVE ANDROSTERONEThe Lancet, 1962
- Modification of Metabolism and Distribution of Lipids by Ethyl ChlorophenoxyisobutyrateNature, 1962
- EFFECTS OF TRIPARANOL (MER-29) ON CHOLESTEROL BIOSYNTHESIS AND ON BLOOD STEROL LEVELS IN MAN*JCI Insight, 1961
- The Specific Assay of Prower-Stuart Factor and Factor VIIActa Haematologica, 1961
- THYROID-ANDROGEN INTERRELATIONS AND THE HYPOCHOLESTEREMIC EFFECT OF ANDROSTERONE*Journal of Clinical Endocrinology & Metabolism, 1959
- Determination of glycerides in blood serumClinica Chimica Acta; International Journal of Clinical Chemistry, 1959
- A Colorimetric Method for the Determination of Serum Glutamic Oxalacetic and Glutamic Pyruvic TransaminasesAmerican Journal of Clinical Pathology, 1957